Public & Patient Series – Liver directed lentiviral gene therapy for inherited cholestatic disorders
Approximately 1 in 2500 neonates develop cholestatic jaundice, often due to rare genetic disorders with no cure and severe morbidity. This talk will explore how innovative lentiviral gene therapies could…
Free
